How much does Systagenix Wound Management Manufacturing, Limited make?

Systagenix Wound Management Manufacturing, Limited reported revenue of £41.2m and a loss of £1.1m in the year to 31 Dec 2025, according to its accounts filed at Companies House.

How many employees does Systagenix Wound Management Manufacturing, Limited have?

Systagenix Wound Management Manufacturing, Limited reported an average of 251 employees in the year to 31 Dec 2025.

Company No. 06682392 · Incorporated 27 Aug 2008

Systagenix Wound Management Manufacturing, Limited

Q: Is Systagenix Wound Management Manufacturing, Limited profitable?

No — Systagenix Wound Management Manufacturing, Limited reported a loss of £1.1m in the year to 31 Dec 2025.

Registered name: SYSTAGENIX WOUND MANAGEMENT MANUFACTURING, LIMITED

Part of Ams Holdco 1 Ltd group

Systagenix Wound Management Manufacturing, Limited made £41.2m revenue and a £1.1m loss in the year to 31 Dec 2025.

Systagenix Wound Management Manufacturing, Limited’s revenue fell 3% to £41.2m in the year to 31 Dec 2025, with a loss of £1.1m and 251 employees. The company is classified under “other business support service activities” and is based in Ashton-Under-Lyne; we hold 4 years of its filed accounts.

Full P&L filedSection N · Administrative and support servicesSIC 82990Other business support service activities n.e.c.

Status: Active
Location: Ashton-Under-Lyne, North West
Age: 18 yrs · since 2008
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2025

Key figures

Revenue

£41.2m

Growth ▼2.7%

Profit

−£1.1m

Growth —

Profit margin

−2.7%

Gross 16.8%

Employees

251

Change ▼4.2%

Profit / employee

−£4.4k

Revenue/employee £164k

Profitable streak

0yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2022	31 Dec 2023	31 Dec 2024	31 Dec 2025
Disclosure	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£44m	£41.4m	£42.3m	£41.2m
Cost of sales	£36.3m	£35.9m	£33.3m	£34.3m
Gross profit	£7.7m	£5.5m	£9m	£6.9m
Operating profit	£1.9m	£430k	£2.3m	£2.9m
Profit before tax	£1.2m	−£1.5m	−£1.1m	£627k
Profit after tax	£1.8m	−£2.3m	−£307k	−£1.1m
Profit (best available)	£1.8m	−£2.3m	−£307k	−£1.1m
Staff costs	£14.4m	£12.4m	£13.6m	£13m
Employees (average)	300	283	262	251
Ratios
Profit margin	4%	−5.6%	−0.7%	−2.7%
Gross margin	17.5%	13.2%	21.3%	16.8%
Revenue per employee	£147k	£146k	£162k	£164k
Profit per employee	£5.8k	−£8.1k	−£1.2k	−£4.4k
Growth (year on year)
Revenue growth	—	▼6.1%	▲2.4%	▼2.7%
Profit growth	—	▼231.1%	—	—
Headcount growth	—	▼5.7%	▼7.4%	▼4.2%
Balance sheet — indirect signals, not revenue
Cash at bank	£1.3m	£365k	£1.9m	£768k
Net assets	£32.2m	£29.9m	£29.6m	£11.4m
Current assets	£44m	£49.4m	£42.4m	£16.4m
Debtors	£6.9m	£8.5m	£5.5m	£6.4m
Deferred income	£1.9m	£1.5m	£2.3m	£1.9m
Source	Accounts · bulk data Sep 2024	Accounts · bulk data Sep 2024	FullAccounts · bulk data Sep 2025	FullAccounts · bulk data Sep 2026

Derived from the latest filing

How the business works

Profit margin: −2.7%; Profit ÷ revenue.
Gross margin: 16.8%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £164k; Revenue ÷ average employees.
Profit per employee: −£4.4k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 4.6%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 15.4%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▼62%; Now £11.4m
Cash at bank: ▼60%; Now £768k
Headcount: ▼4%; Now 251
Deferred income: ▼19%; Now £1.9m
Fixed assets: —; Now —

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Ams Holdco 1 Ltdultimate parent75–100%
Ams Holdco 2 Ltd75–100%
Scapa Group Limited75–100%
First Water Limited75–100%
Systagenix Wound Management Manufacturing, Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (3)

Crawford Manufacturing LimitedRev. — · Profit −£35.9k
Scapa Denver (North) LimitedFigures not disclosed
Scapa Healthcare LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit −£1.1m), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.